UK drugs giant AstraZeneca announces $15 bn investment in China

Beijing (AFP) Jan 29, 2026
British pharmaceutical group AstraZeneca said Thursday that it would invest $15 billion in China through 2030 to expand its medicines manufacturing and research, during a trip by UK Prime Minister Keir Starmer to Beijing. AstraZeneca's chief executive Pascal Soriot was part of a delegation of business leaders accompanying Starmer on his visit. "China... has become a critical contributor